These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17918287

  • 1. Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancer.
    Andreadis C, Iliopoulou C, Sidiras T, Boutis A, Diamantopoulos N, Vahtsevanos K, Gennatas K, Mouratidou D.
    J BUON; 2007; 12(3):341-7. PubMed ID: 17918287
    [Abstract] [Full Text] [Related]

  • 2. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J.
    J Clin Oncol; 2006 Feb 01; 24(4):593-8. PubMed ID: 16380415
    [Abstract] [Full Text] [Related]

  • 3. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1395-9. PubMed ID: 16087298
    [Abstract] [Full Text] [Related]

  • 4. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.
    Laryngoscope; 2006 Sep 01; 116(9):1651-6. PubMed ID: 16954998
    [Abstract] [Full Text] [Related]

  • 5. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM, Lee JK, Cho JS, Lim SC, Chung WK.
    J Otolaryngol Head Neck Surg; 2010 Apr 01; 39(2):142-9. PubMed ID: 20211100
    [Abstract] [Full Text] [Related]

  • 6. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr 01; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B.
    Head Neck; 2005 Jan 01; 27(1):15-21. PubMed ID: 15515158
    [Abstract] [Full Text] [Related]

  • 8. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
    Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Horiuchi C, Yoshida T, Nishimura G, Ishitoya J, Katori H.
    Acta Otolaryngol; 2006 Apr 01; 126(4):408-13. PubMed ID: 16608794
    [Abstract] [Full Text] [Related]

  • 9. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ, Murphy BA, Burkey B, Douglas S, Shyr Y, Netterville J.
    Head Neck; 2007 Apr 01; 29(4):315-24. PubMed ID: 17252600
    [Abstract] [Full Text] [Related]

  • 10. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
    Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY.
    Arch Otolaryngol Head Neck Surg; 2004 Jul 01; 130(7):875-9. PubMed ID: 15262766
    [Abstract] [Full Text] [Related]

  • 11. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, Huang JL, Chang SY.
    Jpn J Clin Oncol; 2008 Aug 01; 38(8):521-7. PubMed ID: 18697758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
    Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E.
    J Clin Oncol; 2013 Mar 01; 31(7):853-9. PubMed ID: 23341517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T, Susaki Y, Saito T, Katsura Y, Ikeda M.
    Acta Otolaryngol; 2013 Jan 01; 133(1):91-8. PubMed ID: 23106387
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V, Parsons JT, Greene BD, Sharma V.
    Head Neck; 2009 Feb 01; 31(2):167-74. PubMed ID: 18853443
    [Abstract] [Full Text] [Related]

  • 17. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
    Lambert L, Fortin B, Soulières D, Guertin L, Coulombe G, Charpentier D, Tabet JC, Bélair M, Khaouam N, Nguyen-Tan PF.
    Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):398-402. PubMed ID: 19394155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.
    J Clin Oncol; 2007 Sep 01; 25(25):3971-7. PubMed ID: 17761982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.